U.S. Markets closed

These Four Marijuana Stocks May Surge On Friday

CORAL GABLES, FL / ACCESSWIRE / March 15, 2019 / The marijuana stock market is constantly evolving as a result of the world slowly gaining a better understanding of the benefits of supporting the global cannabis industry. According to recent statistics, the global legal marijuana market is projected to reach $146.4 billion by the end of 2025. Legal cannabis has gained traction on a global scale due to the fact that consumers are pushing legislators to advocate for legislation in support of marijuana legalization. Additionally, government regulation of cannabis means that products will be manufactured with a set of standards that improves the safety of consumers. Investors looking for potentially lucrative opportunities could benefit from looking into the cannabis industry in the future. Leafbuyer Technologies Inc (LBUY), TILT Holdings Inc (OTCQB:SVVTF), Acreage Holdings Inc (OTCQX:ACRGF), and InMed Pharmaceuticals Inc (IMLFF) represent 4 marijuana stocks reaching new highs on Friday.

Leafbuyer Technologies Inc (LBUY) is considered to be the most comprehensive online resource for information related to cannabis, as well as how to procure products currently available on the market. Consumers expect to have access to pertinent information regarding the products they purchase, even more so if these products will be ingested or applied to the body. In recognition of this fact, Leafbuyer has become the authority on cannabis-related information.

Leafbuyer Technologies Inc (LBUY) made headlines on Wednesday when the Company announced the official launch of the leading mobile application, Greenlight, in Colorado and Oklahoma. The news follows a November 8, 2018 press release announcing the Company's acquisition of Greenlight. Through the Greenlight app, consumers can preorder their favorite cannabis products from participating dispensaries and skip the line when they go to pay and pick them up.

Following the announcement, Kurt Rossner, Chief Executive Officer of Leafbuyer Technologies Inc (LBUY), said, "in this fast-paced industry, we need to stay ahead of technology and continuously improve our offerings to drive more value to our clients. Greenlight is one more platform we have that separates us from our competition, inherently making Leafbuyer a more attractive option to dispensary clients nationwide."

For More Information On Leafbuyer Technologies Inc, Click Here

TILT Holdings Inc (SVVTF), a business to business cannabis company focused on the research, development, manufacturing, and sales of products/services, today announced that the Company's common shares have been approved to begin trading on the OTCQB Venture Market, effective immediately.

Alex Coleman, Chief Executive Officer of TILT, said, "we expect that trading on the OTCQB will increase TILT's access for U.S. institutional and retail investors, allowing them to participate in the significant growth opportunity we are seeing across North America and select international markets. We anticipate increased awareness and understanding of our distinctive business model and growth strategy as a result of our listing on this market."

For More Information On TILT Holdings Inc, Click Here

Acreage Holdings Inc (ACRGF) announced earlier this week that the Company has entered into an agreement to acquire 100% of California-based Kanna, Inc, which holds a license to operate a cannabis dispensary in Oakland, CA. This marks the first dispensary operating license for Acreage in California.

Following the announcement, Kevin Murphy, Founder and Chief Executive Officer of Acreage, said, "I could not be more excited about our first dispensary operation in California, especially one in a limited competitive market. While this is our first, it is nowhere near our last, as we expect to significantly expand our dispensary footprint in the state over the coming months."

For More Information On Acreage Holdings Inc, Click Here

InMed Pharmaceuticals Inc (IMLFF), a biopharmaceutical company developing a proprietary biosynthesis platform technology for the manufacturing of pharmaceutical-grade cannabinoids, provided an update on its drug development program for the treatment of Epidermolysis Bullosa on Wednesday.

Per the details of the announcement, the Company has determined that the clinical development path forward with its investigational drug candidate for the treatment of EB, previously referred to as INM-750, will be optimized by transitioning to an alternative formulation, now designated as INM-755. INM-755 is formulated based on one of the two cannabinoids that comprised INM-750.

For More Information On InMed Pharmaceuticals Inc, Click Here

About marijuanastocks.com

MarijuanaStocks.com is the leading web destination for all things cannabis. Investors can find marijuana-related financial, medical, legal, and social news anytime day or night. Writers are invited to submit cannabis related articles for publication.

Legal Disclaimer

Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. MAPH Enterprises LLC which owns www.MarijuanaStocks.com is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release.

MAPH Enterprises LLC, which owns www.MarijuanaStocks.com, may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. MAPH Enterprises LLC, which owns www.MarijuanaStocks.com, may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two. Midam has been paid an additional $50,000 and 40,000 common restricted shares of Leafbuyer Technologies, Inc. extending the contract another 30 days ending December 31, 2018. Midam has been compensated an additional $50,000 by Leafbuyer Technologies and has extended its period of coverage to January 31, 2019. Midam has been compensated an additional $50,000 by Leafbuyer Technologies and has extended its period of coverage to March 1, 2019. Midam has been compensated an additional $50,000 by Leafbuyer Technologies and has extended its period of coverage to April 1, 2019. We own 77,000 shares of Leafbuyer Technologies. We may buy or sell additional shares of (LBUY) in the open market at any time, including before, during or after the Website and Information, to provide public dissemination of favorable Information about Leafbuyer Technologies Inc. Contact Information:



SOURCE: MarijuanaStocks.com

View source version on accesswire.com: